MFVAX: MassMutual Select Equity Opports A

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Deepen your understanding of Responsible Investing and learn how it can potentially help you build a more successful practice.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

MFVAX MassMutual Select Equity Opports A


Profile

MFVAX - Profile

Vitals

  • YTD Return -4.4%
  • 3 Yr Annualized Return -9.9%
  • 5 Yr Annualized Return -3.5%
  • Net Assets $741 M
  • Holdings in Top 10 38.1%

52 WEEK LOW AND HIGH

$15.42
$10.90
$17.42

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.29%

SALES FEES

  • Front Load 5.50%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 33.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return -4.4%
  • 3 Yr Annualized Total Return 1.9%
  • 5 Yr Annualized Total Return 8.3%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.04%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    MassMutual Select Equity Opportunities Fund
  • Fund Family Name
    MassMutual
  • Inception Date
    May 01, 2000
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Donald Kilbride

Fund Description

The fund invests primarily in equity securities of U.S. companies that the fund's subadvisers believe are financially sound, valued conservatively by the market, and have improving prospects. It typically invests most of its assets in equity securities of U.S. companies, but may invest in foreign securities and American Depositary Receipts ("ADRs"), including emerging market securities. The fund generally will not invest more than 30% of its total assets in foreign securities.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Performance

MFVAX - Performance

Return Ranking - Trailing

Period MFVAX Return Category Return Low Category Return High Rank in Category (%)
YTD -4.4% -37.3% 1980.1% 81.13%
1 Yr -7.8% -73.2% 2122.8% 92.06%
3 Yr -9.9%* -33.7% 190.4% 95.65%
5 Yr -3.5%* -21.2% 99.1% 93.77%
10 Yr 0.3%* -6.4% 38.7% 93.51%

* Annualized

Return Ranking - Calendar

Period MFVAX Return Category Return Low Category Return High Rank in Category (%)
2019 17.3% -72.6% 39.5% 77.55%
2018 -11.9% -67.0% 10.0% 37.61%
2017 -16.1% -32.8% 33.2% 99.42%
2016 14.5% -18.6% 19.7% 2.70%
2015 -25.1% -35.5% 7.8% 98.00%

Total Return Ranking - Trailing

Period MFVAX Return Category Return Low Category Return High Rank in Category (%)
YTD -4.4% -37.3% 1980.1% 81.13%
1 Yr -7.8% -73.2% 2122.8% 92.06%
3 Yr 1.9%* -33.7% 190.4% 73.64%
5 Yr 8.3%* -13.8% 99.1% 51.95%
10 Yr 9.9%* -4.8% 38.7% 51.77%

* Annualized

Total Return Ranking - Calendar

Period MFVAX Return Category Return Low Category Return High Rank in Category (%)
2019 17.3% -72.6% 39.5% 77.55%
2018 -11.9% -67.0% 10.0% 64.66%
2017 21.5% -22.1% 33.2% 27.19%
2016 17.6% -16.4% 26.8% 2.49%
2015 -9.1% -21.4% 106.5% 91.24%

NAV & Total Return History


Holdings

MFVAX - Holdings

Concentration Analysis

MFVAX Category Low Category High MFVAX % Rank
Net Assets 741 M 1.14 K 974 B 56.42%
Number of Holdings 79 1 3529 59.88%
Net Assets in Top 10 232 M 48.8 K 236 B 58.22%
Weighting of Top 10 38.05% 2.3% 100.0% 23.55%

Top 10 Holdings

  1. Microsoft Corp 4.39%
  2. UnitedHealth Group Inc 4.22%
  3. McDonald's Corp 4.19%
  4. Johnson & Johnson 4.18%
  5. Chubb Ltd 3.70%
  6. Nike Inc B 3.69%
  7. Colgate-Palmolive Co 3.64%
  8. Coca-Cola Co 3.56%
  9. PepsiCo Inc 3.31%
  10. Linde PLC 3.19%

Asset Allocation

Weighting Return Low Return High MFVAX % Rank
Stocks
98.83% 80.83% 167.47% 56.00%
Preferred Stocks
0.76% 0.00% 14.67% 0.92%
Cash
0.41% -110.24% 19.17% 65.30%
Other
0.00% -4.07% 83.89% 20.85%
Convertible Bonds
0.00% 0.00% 13.87% 17.76%
Bonds
0.00% 0.00% 72.82% 24.25%

Stock Sector Breakdown

Weighting Return Low Return High MFVAX % Rank
Healthcare
19.06% 0.00% 31.05% 8.12%
Consumer Defense
17.29% 0.00% 32.98% 2.96%
Financial Services
15.98% 0.00% 42.66% 22.08%
Industrials
12.53% 0.00% 28.15% 11.93%
Consumer Cyclical
11.55% 0.00% 50.96% 39.93%
Technology
8.41% 0.00% 38.54% 95.09%
Basic Materials
6.26% -0.14% 13.17% 6.60%
Real Estate
3.34% 0.00% 12.00% 29.27%
Energy
2.12% -1.47% 13.74% 61.84%
Utilities
1.87% 0.00% 29.37% 65.31%
Communication Services
1.59% 0.00% 28.36% 96.95%

Stock Geographic Breakdown

Weighting Return Low Return High MFVAX % Rank
US
85.30% 80.53% 157.79% 92.24%
Non US
13.53% -1.85% 19.64% 3.50%

Expenses

MFVAX - Expenses

Operational Fees

MFVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.29% 0.01% 49.73% 28.71%
Management Fee 0.69% 0.00% 2.00% 76.00%
12b-1 Fee 0.25% 0.00% 1.00% 28.37%
Administrative Fee 0.15% 0.00% 0.95% 61.96%

Sales Fees

MFVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.50% 1.50% 5.75% 52.41%
Deferred Load N/A 0.95% 5.00% N/A

Trading Fees

MFVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.25% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

MFVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 33.00% 0.00% 475.00% 48.72%

Distributions

MFVAX - Distributions

Dividend Yield Analysis

MFVAX Category Low Category High MFVAX % Rank
Dividend Yield 0.00% 0.00% 11.12% 18.00%

Dividend Distribution Analysis

MFVAX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

MFVAX Category Low Category High MFVAX % Rank
Net Income Ratio 1.04% -3.93% 3.34% 57.13%

Capital Gain Distribution Analysis

MFVAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

MFVAX - Fund Manager Analysis

Managers

Donald Kilbride


Start Date

Tenure

Tenure Rank

Mar 28, 2017

3.43

3.4%

Donald J. Kilbride Senior Managing Director, Partner, and Equity Portfolio Manager Don is a portfolio manager in Global Equity Portfolio Management on the Quality Equity team. He manages equity assets on behalf of our clients, drawing on research from Wellington Management’s global industry analysts, equity portfolio managers, and team analysts. Don currently manages Wellington's Dividend Growth and related approaches focusing on large-cap, quality companies with a value orientation. Prior to joining Wellington Management in 2002, Don was a senior investment analyst and director of Non-Technology Research at Greenberg-Summit Partners; his coverage area included energy, basic materials, financial services, aerospace/defense, and transportation (2001 – 2002). He also worked for six years as the director of US Equity Research at The Boston Company (1996 – 2001). Don received his MBA from the University of North Carolina’s Kenan-Flagler Business School (1991) and his BA from the College of the Holy Cross (1986).

John Linehan


Start Date

Tenure

Tenure Rank

Mar 28, 2017

3.43

3.4%

John Linehan is the portfolio manager for the Equity Income Strategy and co-portfolio manager of the US Large-Cap Value Strategy for T. Rowe Price. In addition, he is the chief investment officer of Equity and a member of the firm's US Equity Steering, Equity Brokerage and Trading Control, and Counterparty Risk Committees. Mr. Linehan is Chairman of the Investment Advisory Committee at T. Rowe. He is a large-cap value portfolio manager in the U.S. Equity Division and also co-chair of the Investment Advisory Committee for the Institutional Large-Cap Value Strategy. From February 2010 to June 2014, Mr. Linehan was head of U.S. Equity and chairman of the U.S. Equity Steering Committee. He is a member of the firm's U.S. Equity Steering, Equity Brokerage and Trading Control, and Counterparty Risk Committees. He earned a B.A. from Amherst College and an M.B.A. from Stanford University, where he was the Henry Ford II Scholar, an Arjay Miller Scholar, and the winner of the Alexander A. Robichek Award in finance. Mr. Linehan is a CFA® charterholder.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 34.15 6.42 0.67